here is uncertainty about paperwork quantities at FDA.....i'm not an FDA insider and do not purport to be.
(previous ten items posted yesterday to Ihub......stockhouse is another chock -full of Verisante commentary from a more Canadian investor community.)
11. Some say when there is blood in the streets as there clearly is here with Verisante's Friday shaking of the confidence of some VRSEF and VRS shareholders. So, it's time to BUY BUY BUY, right?!........it's a risky venture but, the science is very good and seems very legitimate from this man(hongkongwalt aka walt flowers' perspective) i have attended lectures by the inventor, he's good! his competition hasn't replicated his efforts yet nor can they in my opinion.... There is a great deal of Academic integrity here!......this looks to be an FDA review time-commitment here(just my perception and i truly hope and have confidence that it will ring out to be true because i believe and trust that the professional scientists at FDA don't want to anger an AARP(populated U.S.) by declining new functional "real-time" cancer detection technology. my understanding is that FDA is in possession of this evidence and has been so in possession of this evidence for at least six months now. the data is 6 double blinded studies of Aura Detection of all types of skin cancers(in real-time) vs Doctors best diagnosis(cream of the crop board trained derms, mind you). The double blind part is the biopsies were taken for confirmation....absent the MD's knowledge of the lesion scanning results by Aura. all of this is my best understanding as a 2 year shareholder and understander/believer the technology is/should be adopted. (IMHO) do your own homework. RISK/REWARD=HI Less
